Navigation Links
New drug shows promise against multiple sclerosis
Date:11/1/2011

An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America. It usually strikes young adults and is more common in women than in men.

The study, carried out by researchers at the University of California, San Francisco (UCSF) Medical Center, and involving hospitals in the United States, Canada, and Europe, is described this week in the British medical journal Lancet.

The study involved patients with relapsing-remitting MS, a form of the disease marked by the accumulation of lesions in the brain and spinal cord and periodic "attacks" of neurological impairment.

The 220 patients were randomly enrolled into four groups two that received injections of the monoclonal antibody Ocrelizumab at two different doses, one that received the standard multiple sclerosis drug interferon-beta, and one "control" group that was given a placebo.

The doctors gauged the effectiveness of each treatment by performing monthly magnetic resonance imaging (MRI) brain scans of the patients and counting the number of visible marks that indicate inflamed lesions, a hallmark of the disease. They also compared the severity and frequency of neurological "attacks" that cause loss of vision, incoordination, weakness and numbness, among other symptoms.

The results of this trial showed that patients who received the drug generally fared well and showed fewer signs of the disease than patients who receive a placebo or the standard Interferon treatment. Overall, the trial found that Ocrelizumab led to a 89 percent reduction in the formation of brain lesions, and it also reduced the number of new multiple sclerosis attacks over 24 weeks. During this relatively short-term study, interferon performed no better than placebo on these outcomes.

"It really is
'/>"/>

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-4608
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Preterm birth rate shows three year improvement in most states
2. Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation
3. Novel approach to treat proliferative vitreoretinopathy shows promise
4. New therapy shows promise for treating cardiovascular disease
5. More Evidence Shows Newer Forms of Pill Raise Clot Risk, FDA Says
6. New oncolytic virus shows improved effectiveness in preclinical testing
7. Clinical trial shows first evidence that anal cancer is preventable
8. Through-the-nipple breast cancer therapy shows promise in early tests
9. Compound found in common wart treatment shows promise as leukemia therapy
10. Study shows why underrepresented men should be included in binge eating research
11. HIV Medication Patch Shows Promise in Early Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... WI (PRWEB) October 25, 2014 ... tax-advantaged medical and other benefits account management services, ... to help employers save on taxes, reduce administrative ... Suites provide tax savings and the efficient handling ... pick the Suite that best meets their goals ...
(Date:10/25/2014)... October 25, 2014 Market ... Diagnostics Industry, 2009-2019 is a professional and ... Molecular Diagnostics industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Molecular Diagnostics listing their product ...
(Date:10/25/2014)... 2014 Homeowners that are wondering how ... need wonder no more. Clean Crawls gives 5 ... out for when it comes to insulation in their ... article released by Clean Crawls, can cause problems throughout ... insulation that has deteriorated, become damp, or been infested ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 Mesothelioma researchers ... continued to receive pemetrexed (Alimta), after his combination drug ... the full story , just posted on the Surviving ... Uji Tokushukai Medical Center in Japan suggests that “maintenance ... mesothelioma patients who cannot tolerate higher doses of ...
(Date:10/25/2014)... 2014 (HealthDay News) -- Interrupting blood supply to an arm ... risks associated with the surgery, according to a new study. ... blood supply to the heart to be able to operate ... will reduce its ability to produce energy because it doesn,t ... another large muscle, such as an arm or a leg, ...
Breaking Medicine News(10 mins):Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:5 Signs Indicating That Insulation Needs Replacing as Told By Clean Crawls in Recent Article 2Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2
... tremors and other motor problems , FRIDAY, April 2 ... in a gene called LRRK2 may cause Parkinson,s disease ... using genetically engineered mice, the Mount Sinai School of ... controls motor performance. Dopamine is a neurotransmitter. The mutation ...
... -- In a move that could change the way ... state-of-the-art Siemens Artis zeego medical imaging systems that provide ... a quality never before attainable. With more complete information, ... detailed surgical plan, and provide more targeted surgical treatment. ...
... somewhere other than a crib , FRIDAY, April 2 (HealthDay ... die from sleep-related causes than infants in any other ethnic ... of Illinois, where the research was conducted, black infants ... Researchers in the Child Health Data Lab at Children,s Memorial ...
... ... True announces a partnership agreement with Agog Creative Group to become ... of music and spoken-word audio products. The Relaxation Company products include ... which have sold over one million copies. The Relaxation Company products ...
... ... new attention, blasting back at racist accusations leveled against the tea party movement ... Representatives Barney Frank, John Lewis and others. A major distribution deal and an ... is reaching even further into the mainstream debate. , ...
... users reveal misuse of antibiotics, including sharing leftover ... News) -- Medical misinformation can spread quickly on ... for sharing vital and correct health information, a ... and MixedInk in New York City identified more ...
Cached Medicine News:Health News:Operating room radiography to transform surgery 2Health News:Operating room radiography to transform surgery 3Health News:Sleep-Related Death Rate Higher Among Black Infants 2Health News:Sounds True Announces Licensing Partnership with The Relaxation Company, Becomes Market-Leader in Benefit-Oriented Sound Healing Music 2Health News:Sounds True Announces Licensing Partnership with The Relaxation Company, Becomes Market-Leader in Benefit-Oriented Sound Healing Music 3Health News:TEA PARTY MOVIE Goes Mainstream Blasting Racist Accusations from Left-wing Media and Big Government Politicians 2Health News:Medical Misinformation Can Spread Quickly Via 'Tweets' 2Health News:Medical Misinformation Can Spread Quickly Via 'Tweets' 3
(Date:10/25/2014)... , Oct. 24, 2014 Burzynski Research ... and Drug Administration (FDA) has given the company permission ... AS2-1 in patients > 3 months of age with ... be placed in one of five treatment groups based ... received prior treatment for DIPG. The primary study endpoint ...
(Date:10/25/2014)... N.C. , Oct. 24, 2014  As ... can provide a company access to diverse skill ... markets, and round-the clock business hours for efficiency. ... difficult hurdles. According to recent ... disappointments, such as seeing a project not move ...
(Date:10/22/2014)...  Cephasonics, a technology-innovation leader with a game-changing embedded-ultrasound ... Ultrasound Box™-1), the first product in a new family ... Cephasonics for purchase by companies to rebrand with their ... showcasing the cQUB-1 for the first time at CMEF ... Chongqing, China from October 23 to 26. ...
Breaking Medicine Technology:Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma 2Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3
... April 27, 2011 ACCESS PHARMACEUTICALS, ... leveraging its proprietary drug-delivery platforms to develop treatments in areas ... Nursing Society (ONS) Congress at the Boston Convention and Exhibition ... (#652) will be displayed in the Exhibition Hall of the ...
... PharmaTech (Cayman) Inc. (NYSE: WX ) today ... 20-F for the year ended December 31, 2010 with ... be accessed on WuXi PharmaTech,s website at http://www.wuxiapptec.com ... provide a hard copy of its annual report on ...
Cached Medicine Technology:Access Pharmaceuticals to Attend the 36th Annual Oncology Nursing Society Congress 2Access Pharmaceuticals to Attend the 36th Annual Oncology Nursing Society Congress 3
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support....
12mm Blades, Maximum Spread 18mm, Spring Action, Wire - Pediatric; in stainless steel...
15mm Open Blades, 30mm Maximum Blade Spread; in Titanium....
5mm Gently Curved Wing Span, With Centering Pin, Low Profile; in stainless steel....
Medicine Products: